H.C. Wainwright Upgrades Structure Therapeutics (GPCR) on Massive Arbitrage Opportunity for Oral GLP-1 [Yahoo! Finance]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance
Wainwright analyst Ananda Ghosh raised the firm's price target on Structure Therapeutics to $90 from $60 with a Buy rating on the shares. The firm suggested that the company's titration strategy has been validated by key opinion leaders. As payer economics push oral GLP-1s toward Tier 1 therapy status, H.C. Wainwright views Structure Therapeutics' current valuation as a significant arbitrage opportunity when compared to recent industry deal metrics. Due to strong M&A potential and encouraging Phase 2 data, the company is positioned for future growth or acquisition. Earlier on December 12, Morgan Stanley analyst Terence Flynn raised the firm's price target on Structure Therapeutics to $125 from $120 while keeping an Overweight rating on the shares. Flynn informed investors that the regulatory and political uncertainties that weighed on the biopharma sector in 2025 are expected to fade in 2026. This shift is projected to redirect market attention toward the industry's core business pe
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Can This Stock Double Again in 2026? [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.MarketBeat
- Structure Therapeutics (GPCR) valuation check after Phase 1 obesity candidate ACCG-2671 enters first-in-human trial [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity [Yahoo! Finance]Yahoo! Finance
GPCR
Sec Filings
- 1/5/26 - Form 8-K
- 12/10/25 - Form 8-K
- 12/10/25 - Form 424B5
- GPCR's page on the SEC website